The effects of polymyxin B-immobilized fiber hemoperfusion on respiratory impairment in endotoxemic pigs
- PMID: 24998959
- DOI: 10.1272/jnms.81.130
The effects of polymyxin B-immobilized fiber hemoperfusion on respiratory impairment in endotoxemic pigs
Abstract
Purpose: This study investigated the effects of direct hemoperfusion with polymyxin B-immobilized fibers (PMX-DHP) on respiratory impairment in endotoxemic pigs.
Materials and methods: Thirteen anesthetized, mechanically ventilated pigs were divided into PMX-DHP (n=7) and control (n=6) groups. All pigs were hemodynamically monitored with the pulse index contour cardiac output (PiCCO) system (Pulsion Medical Systems, Munich, Germany) and infused intravenously with live Escherichia coli (LD50). In the PMX-DHP group, an arteriovenous extracorporeal circuit with a PMX column was applied for 30 to 150 minutes after endotoxin injection. We analyzed the laboratory data, arterial blood gas levels, and PiCCO variables (extravascular lung water [EVLW] and pulmonary vascular permeability index [PVPI]). Furthermore, we performed computed tomography of the chest in all pigs. The data were statistically analyzed with Student's t-test, the chi-square test, and the Mann-Whitney U-test.
Results: With PMX-DHP endotoxemia significantly decreased and blood pressure increased 150 minutes after endotoxin injection. PiCCO revealed more cases of decreased EVLW in the PMX-DHP group. PVPI increased after endotoxin infusion in both groups. Computed tomography showed improvements in the PMX-DHP group. The survival rate was greater in the PMX-DHP group (100%) than in the control group (71%).
Conclusion: PMX-DHP is effective for treating respiratory impairment and contributes to the decreased mortality rate in the endotoxemic pigs.
Similar articles
-
Efficacy of direct hemoperfusion using polymyxin B-immobilized fiber column (PMX-DHP) in rapidly progressive interstitial pneumonias: results of a historical control study and a review of previous studies.Ther Adv Respir Dis. 2017 Jul;11(7):261-275. doi: 10.1177/1753465817708950. Epub 2017 May 30. Ther Adv Respir Dis. 2017. PMID: 28554260 Free PMC article. Review.
-
Polymyxin B hemoperfusion: a mechanistic perspective.Crit Care. 2014 Jun 9;18(3):309. doi: 10.1186/cc13912. Crit Care. 2014. PMID: 25043934 Free PMC article. Review.
-
Effect of hemoperfusion using polymyxin B-immobilized fibers on non-shock rat sepsis model.J Surg Res. 2011 Dec;171(2):755-61. doi: 10.1016/j.jss.2010.04.058. Epub 2010 May 22. J Surg Res. 2011. PMID: 20655065
-
Effect of polymyxin B-immobilized fiber hemoperfusion on respiratory impairment, hepatocellular dysfunction, and leucopenia in a neonatal sepsis model.Pediatr Surg Int. 2010 Feb;26(2):187-93. doi: 10.1007/s00383-009-2476-x. Epub 2009 Oct 3. Pediatr Surg Int. 2010. PMID: 19802625
-
Direct hemoperfusion with polymyxin B-immobilized fiber improves shock and hypoxemia during endotoxemia in anesthetized sheep.J Endotoxin Res. 2002;8(6):419-26. doi: 10.1179/096805102125001019. J Endotoxin Res. 2002. PMID: 12542853
Cited by
-
Clinical Efficacy of Polymyxin B in Patients Infected with Carbapenem-Resistant Organisms.Infect Drug Resist. 2021 May 28;14:1979-1988. doi: 10.2147/IDR.S312708. eCollection 2021. Infect Drug Resist. 2021. PMID: 34093026 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical